Folate-Targeted Liposomal Delivery of a Ru(II)-Based Photosensitizer for Photodynamic Tumor Therapy via Pyroptosis Induction.

Authors

Can Shao, Kuang Xu, Jie Peng, Manchang Kou, Ke Xu, Xiaoliang Tang, Zhifa Shen, Jiaxi Ru

Published in

Advanced healthcare materials. Pages e71351. Jun 12, 2026. Epub Jun 12, 2026.

Abstract

Pyroptosis has emerged as a promising antitumor strategy offering unique advantages in overcoming apoptosis resistance and activating antitumor immunity. However, the development of drugs capable of achieving spatiotemporally controlled pyroptosis remains a challenge. Herein, we engineered a folate-targeted liposomal nanoplatform to deliver a Ru(II) complex photosensitizer (Ru-Thi@Lipo-FA) for pyroptosis-mediated photodynamic therapy. The Ru(II) complex (Ru-Thi), acting as a photosensitizer, can produce singlet oxygen and superoxide anions and facilitate the photocatalytic oxidation of NADH through multiple mechanisms to kill tumor cells under white light irradiation. Additionally, we encapsulated the complex within folic acid-modified liposomes, which markedly boosted cellular uptake efficiency and tumor targeting, leading to improved therapeutic effects. Mechanistic investigations demonstrated that light-triggered reactive oxygen species generation activates the caspase-3/GSDME-mediated pyroptosis pathway. This study demonstrated a rationally designed, targeted nanoplatform that utilizes a multifunctional Ru(II)-based photosensitizer and induces pyroptosis, providing a viable approach to improve the efficacy of tumor photodynamic therapy.

PMID:
42286834
Bibliographic data and abstract were imported from PubMed on 13 Jun 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.